Literature DB >> 25864074

Factors associated with poor outcomes of hospitalized myasthenia gravis.

Sim S Tin1, Viroj Wiwanitkit.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25864074      PMCID: PMC4727642          DOI: 10.17712/nsj.2015.2.20150123

Source DB:  PubMed          Journal:  Neurosciences (Riyadh)        ISSN: 1319-6138            Impact factor:   0.735


× No keyword cloud information.
We would like to discuss the recent publication by Tiamkao et al1 entitled ‘Factors associated with poor outcomes of hospitalized myasthenia gravis’. Tiamkao et al1 noted that “hospital category, pneumonia, and respiratory failure” are the 3 main factors associated with poor outcome. Based on the nature of a retrospective study, there are some points to be addressed. First, it cannot exclude any possible concomitant illness in the studied cases. Also, the data on “cost” in the present study should be carefully analyzed, as there were a lot of changes in the currency value in Thailand during the studied period. In addition, many previous reports mentioned the variability of clinical outcome due to pathological underlying myasthenia gravis (thymomatous versus non-thymomatous), and the methods used for treatment (medical treatment, surgical manipulation, and other techniques).2 Finally, the role of underlying genetics should also be discussed. It is reported that patients with the HLA-B8-DR3 haplotype, especially among younger, female patients usually have more severe diseases.3 No reply received from the author.
  3 in total

1.  The autoimmune spectrum of myasthenia gravis: a Swedish population-based study.

Authors:  F Fang; O Sveinsson; G Thormar; M Granqvist; J Askling; I E Lundberg; W Ye; L Hammarström; R Pirskanen; F Piehl
Journal:  J Intern Med       Date:  2014-11-13       Impact factor: 8.989

Review 2.  Paraneoplastic myasthenia gravis: immunological and clinical aspects.

Authors:  G O Skeie; F Romi
Journal:  Eur J Neurol       Date:  2008-08-20       Impact factor: 6.089

3.  Prevalence of factors associated with poor outcomes of hospitalized myasthenia gravis patients in Thailand.

Authors:  Somsak Tiamkao; Sineenard Pranboon; Kaewjai Thepsuthammarat; Kittisak Sawanyawisuth
Journal:  Neurosciences (Riyadh)       Date:  2014-10       Impact factor: 0.906

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.